NCT04856774 Trial of SHR-1701 Plus BP102 in Subjects With Selected Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT04830501 Study of the of the Safety and Tolerability of TT-00434 in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT04826341 A Phase I/II Study of Sacituzumab Govitecan Plus Berzosertib in Small Cell Lung Cancer, Extra-Pulmonary Small Cell Neuroendocrine Cancer and Homologous Recombination-Deficient Cancers Resistant to PARP Inhibitors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04811118 The Comparison of the Pharmacokinetics of Albumin-bound Docetaxel and Taxotere Status UNKNOWN Phase PHASE1
NCT04808362 Phase 1/2 Study to Evaluate Safety, PK and Efficacy of the MYC-Inhibitor OMO-103 in Solid Tumours Status TERMINATED Phase PHASE1/PHASE2
NCT04778839 Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors. Status RECRUITING Phase PHASE1
NCT04768868 The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors Status UNKNOWN Phase PHASE1
NCT04747470 Study to Assess the Effects of GS-3583 in Participants With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT04746612 First in Human Study to Evaluate the Safety, Tolerability of HH30134 in Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT04727554 Study of AMG 994 Monotherapy and AMG 994 and AMG 404 Combination Therapy in Participants With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT04716634 Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors Status COMPLETED Phase PHASE2
NCT04699929 A Study to Evaluate YH001 in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT04699643 FGFR4 Inhibitor EVER4010001 in Combination With PD-1 Inhibitor Pembrolizumab in Patients With Advanced Solid Tumors Status UNKNOWN Phase PHASE1/PHASE2
NCT04675060 Effect of High-fat Meal on the Pharmacokinetics of TQ-B3139 Capsules Status UNKNOWN Phase PHASE1
NCT04672460 A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT04659096 A Study of ION537 in Patients With Molecularly Selected Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT04626635 A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers Status RECRUITING Phase PHASE1/PHASE2
NCT04623892 A Study to Evaluate the Tolerance and Pharmacokinetics of TQB2618 Injection in Subjects With Advanced Solid Tumors Status UNKNOWN Phase PHASE1